+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ankylosing Spondylitis Drug"

Ankylosing Spondylitis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Ankylosing Spondylitis Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Ankylosing Spondylitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Ankylosing Spondylitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • April 2023
  • 538 Pages
  • Global
From
Africa Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Africa Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 100 Pages
  • Africa
From
Ankylosing Spondylitis Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Thumbnail Image

Ankylosing Spondylitis Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • December 2023
  • 255 Pages
  • Global
From
United Kingdom Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Kingdom Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Kingdom
From
United Arab Emirates Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
China Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

China Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • China
From
France Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

France Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • France
From
India Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

India Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • India
From
Saudi Arabia Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Saudi Arabia Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • Saudi Arabia
From
South Korea Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

South Korea Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • South Korea
From
Germany Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Germany Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • Germany
From
Ankylosing Spondylitis (Bekhterev's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 140 Pages
  • Global
From
Axial Spondyloarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Axial Spondyloarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 145 Pages
  • Global
From
Ankylosing Spondylitis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Ankylosing Spondylitis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 81 Pages
  • Global
From
Ankylosing Spondylitis Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Ankylosing Spondylitis Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2022
  • 91 Pages
  • Global
From
Russia Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Russia Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • Russia
From
Loading Indicator

The Ankylosing Spondylitis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Ankylosing Spondylitis is a chronic inflammatory disorder that affects the spine and other joints, and is characterized by pain and stiffness. Ankylosing Spondylitis Drugs are used to reduce inflammation and pain, and to improve mobility. These drugs are typically administered orally or by injection, and may include biologics, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroids. The Ankylosing Spondylitis Drug market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include AbbVie, Amgen, Pfizer, Janssen, and Novartis. Show Less Read more